Filing Details

Accession Number:
0001209191-21-036101
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-26 20:25:56
Reporting Period:
2021-03-19
Accepted Time:
2021-05-26 20:25:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG Laboratory Analytical Instruments (3826) 455614458
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786391 J. Benjamin Hindson C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-03-19 11,169 $0.00 47,805 No 4 A Direct
Class A Common Stock Disposition 2021-05-24 351 $162.66 47,454 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (right to buy) Acquisiton 2021-03-19 27,922 $0.00 27,922 $177.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,922 2031-03-19 No 4 A Direct
Footnotes
  1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
  2. The number of shares beneficially owned following the reported transaction is as of March 19, 2021.
  3. These shares were sold to cover tax withholding obligations in connection with the vesting of RSUs.
  4. The number of shares beneficially owned following the reported transaction is as of May 24, 2021.
  5. This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.